Evidence map›Paper›PMID 35397700›Full record

ArticleVirchows Archiv : an international journal of pathology2022

A primary rectal neoplasm with novel DDX5-TFEB fusion.

Mengxin Zhang, Xiaoxue Yin, Junru Chen, Sha Zhu, Linmao Zheng, Hao Zeng, Qiao Zhou, Ni Chen

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mengxin ZhangPathology Department and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xiaoxue YinPathology Department and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Junru ChenDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Sha ZhuDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Linmao ZhengPathology Department and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Hao ZengDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Qiao ZhouPathology Department and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
Ni ChenPathology Department and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. chenni1@163.com.ORCID http://orcid.org/0000-0002-0628-0723
Sichuan University · CN

Funding

National Natural Science Foundation of China 81872108National Natural Science Foundation of China NSFC 81872107Sichuan STA Key Programs 2021YFS0114
6 · The paper itself

Abstract

We report a case of primary rectal neoplasm with a novel DDX5-TFEB fusion in a 14-year-old boy. Histologically, the neoplasm was composed of epithelioid tumor cells with abundant clear to eosinophilic cytoplasm, arranged in nests with rich stromal capillary vasculature. Immunohistochemically, the tumor cells were positive for transcription factor EB (TFEB) and negative for PAX8, TFE3, HMB45, and PCK. TFEB gene rearrangement and low-level amplification were identified using break-apart fluorescence in situ hybridization. Next-generation sequencing identified a heretofore unreported DDX5-TFEB gene fusion, which was confirmed by using reverse transcription-polymerase chain reaction and Sanger sequencing. The major morphological differential diagnoses include perivascular epithelioid cell tumor, microphthalmia-associated transcriptional factor family translocation renal cell carcinoma, and alveolar soft part sarcoma. The morphological, immumophenotypical, and genetic characteristics of this tumor did not fit well with current classification, but it may represent an unusual PEComa-like tumor with a novel DDX5-TFEB fusion.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsPerivascular Epithelioid Cell NeoplasmsRectal NeoplasmsAdolescentBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, TumorDEAD-box RNA HelicasesGene FusionHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMaleTranslocation, GeneticBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, TumorDdx5 protein, humanDEAD-box RNA HelicasesTFEB protein, humanDDX5Gene fusionRectal neoplasmTFEB

Identifiers

PMID35397700
OpenAlexW4223562159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.